hepatitis C

Good and bad news for Gilead
BioPharma Dive
Sat, 10/22/16 - 03:13 pm
Gilead Sciences
selonsertib
HIV
hepatitis C
NASH
Gilead May Lose Sovaldi’s European Patent
Investopedia
Fri, 10/7/16 - 10:25 pm
Gilead Sciences
Sovaldi
Europe
patents
hepatitis C
FDA Warning Adds to Gilead’s Drug Woes (GILD)
Investopedia
Fri, 10/7/16 - 08:59 am
FDA
warnings
hepatitis C
Gilead Sciences
FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk
RAPS.org
Tue, 10/4/16 - 10:20 pm
FDA
warnings
hepatitis C
hepatitis B
AbbVie Receives FDA Ranking for Hepatitis C Therapy
Yahoo/GuruFocus
Mon, 10/3/16 - 09:51 pm
AbbVie
FDA
hepatitis C
glecaprevir/pibrentasvir
How Gilead Dominates the HCV Space
Market Realist
Mon, 09/26/16 - 09:50 am
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Gilead Sciences: Are Hepatitis C Sales Getting Better?
Barron's
Fri, 09/23/16 - 10:13 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
J&J advances through PhII with a promising hep C triple and 100% cure rate
Endpoints
Fri, 09/9/16 - 10:21 am
JNJ
hepatitis C
clinical trials
odalasvir
AL-335
Olysio
Achillion
Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine
Stat/Pharmalot
Tue, 09/6/16 - 03:08 pm
Gilead Sciences
hepatitis C
Ukraine
Doctors Without Borders
Gilead: Forbes Is Salty Over The Vermont Initiative
Seeking Alpha
Mon, 08/29/16 - 04:09 pm
Gilead Sciences
Vermont
hepatitis C
drug pricing
ACLU threatens suit against Colorado as it ups pressure in hep C drug fight
Fierce Pharma
Tue, 08/23/16 - 12:38 pm
ACLU
Colorado
hepatitis C
Medicare
Medicaid
Break Up Gilead Sciences? Not So Fast
Barron's
Fri, 08/19/16 - 11:46 am
Gilead Sciences
HIV
hepatitis C
Gilead Sciences, Inc: Why A Split Up Is Much Needed For Turnaround Growth?
Bidness, ETC
Thu, 08/18/16 - 08:47 am
Gilead Sciences
HIV
hepatitis C
Gilead Sciences, Inc. HCV Script Data: Epclusa May Lighten The Blow
Bidness, ETC
Mon, 08/15/16 - 10:00 am
Gilead Sciences
hepatitis C
Epclusa
prescription data
Gilead to get attorney fees in hepatitis C patent fight with Merck
Yahoo/Reuters
Thu, 08/11/16 - 11:35 pm
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
Could a Spin-off of its Hepatitis C Division be in Gilead's Future?
TheStreet.com
Mon, 08/1/16 - 03:51 pm
Gilead Sciences
hepatitis C
spinoffs
M&A
Medivation
As hep C sales decline, Wall Street wonders what Gilead does for its next act
Stat
Wed, 07/27/16 - 09:49 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead trims guidance as Hepatitis C sales slip
BioPharma Dive
Mon, 07/25/16 - 06:27 pm
Gilead Sciences
hepatitis C
earnings
Gilead secures European approval for new hepatitis C drug
BioPharma Dive
Mon, 07/11/16 - 11:23 am
Gilead Sciences
Europe
hepatitis C
Epclusa
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent

Pages